date:Jul 18, 2012
in various forms, including as chelates so that it can be easily digested.
According to Innophos, AMT complements its Kelatron business, which was acquired by Innophos in November 2011. The combined businesses strengthen Innophos' position in US bioactive mineral ingredient market, and will enable the company to achieve annual revenues of approximately $30m.
Innophos chairman and CEO Randy Gress said the acquisition is a part of the company's strategy to expand in product categories closely rela